1Gaede P, Vedel P, Parring HH, et al. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lallcet1999, 353: 617-620.
2Ilkova H, Glaser B, Tunckale A, et al. Induction of longterm glycemic control in newly diagnosed Type 2 Diabetic patients by transient intensive insulin treatment. Diabetes care 1997,20:1353-1356.
3Abraira C, Colwell J, NuUal F, et al. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type Ⅱ Oiabetes (VACSDM) Groop. Cardiovascular events alld conelates in ale Veterans Affairs diabetes feasibility trial. Arch Intern Med 1997, 157: 181-188.
4UK Prospective Diabetes Study Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients widl type 2 diabetes (UKPDS33).Lancet 1998,352: S37-S53..
5UK Prospective Diabetes Study Group. Effect of intensive blood - glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS34). Lancet 1998, 352 : 854 -S65.
6Shichiri M, Kishikawa H, Ohkubo Y, et al. Long - term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000, 23 (Suppl 2) : B21 -29.
7American Diabetes Association. Implication of the United Kingdom Prospective Diabetes study. Diabetes Care 2002, 25(Suppl 1): S28-32.
8Chantelau E, Kohner EM. Why some cases of retinopathy worsen when diabetic control improves. BMJ 1997, 3 15:1105-1106.
10Abraira C, Duckwoth W, McCamen M. Seven years VA Cooperative Study on glycemic control and complications [abstract]. Diabetes 2000, 49(Suppl), 1 :A1422.
8UKPDS Group Intensive blood- glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS33) Lancet, 1998,352 (9131):837 ～ 853
